Physician profile
Tye Brian Jensen
NPI 1245515725
$650.47
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $417 · 2022: $204 · 2023: $29.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $29.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $29.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $234.32 | 2021-2023 | |
| Amgen INC. | $85.13 | 2021-2022 | |
| Astellas Pharma US INC | $85.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $66.19 | 2021 | |
| Currax Pharmaceuticals LLC | $28.83 | 2021-2022 | |
| Lilly USA, LLC | $28.20 | 2021-2022 | |
| Organon LLC | $23.60 | 2021-2022 | |
| Eisai INC. | $21.62 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.65 | 2021 | |
| Almatica Pharma LLC | $16.02 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.80 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.35 | 2021 | |
| Pfizer INC. | $11.85 | 2022 | |
| Genentech USA, INC. | $4.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tye Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.